Biotechnology is a field that combines data, technology, and biology to improve scientific processes, and AI has the potential to further empower the biopharmaceutical industry. In this episode of NVIDIA AI PodcastHost Noah Kravitz speaks with Chris Gibson, co-founder and CEO of Recursion, about how the company is using AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and reducing discovery costs.
Timestamps
0:58: Background on recursion
6:23: Recursion's approach to drug discovery
12:06: Empirical data generation and generative AI prediction
17:46: How supercomputing is accelerating drug discovery
22:32: What is biotechnology?
29:15: The future: using natural language prompts to work with AI systems
31:44: Recursion's plans for the future
You may also like:|
Caristo Diagnostics has developed an AI-based solution to detect coronary inflammation in cardiac CT scans. Dr. Keith Channon, co-founder and chief medical officer of the company, discusses how Caristo uses AI to improve treatment plans and risk predictions by providing patient-specific readings.
Physician-led healthcare AI company Harrison.ai has created annalise.ai. This AI solution acts as a “spell checker” for radiologists, flagging critical findings to improve the speed and accuracy of radiology image analysis, thereby reducing misdiagnoses. Harrison.ai CEO and co-founder Aengus Tran discusses the potential for autonomous AI systems to scale global healthcare capacity.
Matice Founder Jessica Whited on Using Regenerative Species to Achieve Medical Advances – Ep. 198
Matice Biosciences is using AI to study tissue regeneration in animal species known as super-regenerators, such as salamanders and planarians. Jessica Whited, a regenerative biologist at Harvard and co-founder of Matice Biosciences, discusses the company’s goal of leveraging regenerative species and AI to develop new treatments to help humans heal from injuries without scarring.
Bojan Tunguz and Johnny Israeli on how AI and crowdsourcing can boost vaccine distribution – Ep. 195
Artificial intelligence is teaming up with crowdsourcing to improve the thermostability of mRNA vaccines, making their distribution more accessible worldwide. Bojan Tunguz, a physicist and senior systems software engineer at NVIDIA, and Johnny Israeli, senior manager of AI and cloud software at NVIDIA, discuss the fusion of AI, crowdsourcing, and machine learning and its potential in drug discovery.
Subscribe to the AI podcast
Get the AI Podcast through iTunes, Google Play, Amazon Music, Casting boxDog hunter, Cloudy, FM playerPocket molds, Bay of pods, Pod beanPodCruncher, PodKicker, Cloud of sound, Spotify, Stapler and Tune in.
Improve AI Podcast: Have a few minutes to spare? Complete This listener survey.
Leave feedback about this